CONCLUSION SpO2 alone is not adequate for monitoring alveolar ventilation during sedated endoscopy under oxygen supplementation due to possible delays in detecting alveolar hypoventilation in patients. Even if SpO2 decreases by only 1% during the procedure and its level remains near 100%, physicians should consider the onset of severe alveolar hypoventilation, which requires immediate intervention.
INTRODUCTION
Sedation is widely performed during endoscopy to decrease patient anxiety, discomfort and pain. Sedation using a combination of opioids and benzodiazepines, however, depresses the responsiveness of the central respiratory drive to arterial carbon dioxide tension, resulting in arterial hypoxaemia accompanied by alveolar hypoventilation.
(1) Pulse oximetry (SpO2) monitoring and oxygen supplementation are therefore used to manage hypoxaemia during sedated endoscopy. (1) Despite its widespread use, the measurement of SpO2 has been reported to have limited utility during oxygen supplementation. (1) (2) (3) (4) (5) This is because SpO2 measures arterial oxygen saturation and not alveolar ventilation. (1) While breathing room air, alveolar hypoventilation causes a decrease in alveolar oxygen partial pressure (PAO2) and an increase in alveolar carbon dioxide partial pressure (PACO2). This leads to an immediate decrease of SpO2 in response to the decrease in arterial oxygen partial pressure resulting from the decrease in PAO2. In contrast, supplemental oxygen increases inspiratory oxygen partial pressure, and PAO2 remains high despite the increase in PACO2 caused by alveolar hypoventilation. Therefore, SpO2 may be overestimated because of the supplementation of oxygen without the recovery of ventilation, even when significant alveolar hypoventilation occurs. (3, 5) Capnography is acknowledged as a superior method for the evaluation of ventilation in patients. It monitors the end-tidal carbon dioxide (etCO2) levels, which is theoretically more sensitive to alveolar hypoventilation than SpO2, and is the standard for general anaesthesia managed with bronchial intubation. (4) Capnography has also been clinically demonstrated to be an earlier indicator of respiratory distress than SpO2. (6, 7) The present study was designed to evaluate the masking effect of oxygen supplementation in SpO2 when alveolar hypoventilation develops during sedated diagnostic colonoscopy, using a novel non-intubated capnography system.
METHODS
A total of 70 patients (mean age 56.8 ± 11.7 years) who underwent sedated diagnostic colonoscopy were enrolled into the study. The patients fulfilled the inclusion criteria and agreed to participate in the study. METHODS A total of 70 patients undergoing sedated diagnostic colonoscopy were randomly divided into two groupsoxygen supplementation group (n = 35) and room air breathing group (n = 35). SpO2 and end-tidal carbon dioxide (etCO2) were measured by non-intubated capnography during the procedure for all the patients.
RESULTS
The rise of etCO2 caused by alveolar hypoventilation was comparable in the two groups after sedation.
SpO2 was significantly higher in the oxygen supplementation group than in the room air breathing group (98.6% ± 1.4% vs. 93.1% ± 2.9%; p < 0.001) at peak etCO 2 , and oxygen supplementation caused SpO2 to be overestimated by greater than 5% when compared with room air. SpO2 at peak etCO2 was reduced from the baseline before sedation for the oxygen supplementation and room air breathing groups by 0.5% ± 1.1% and 4.1% ± 3.1%, respectively (p < 0.001).
Patients were randomised into two study groups: (a) oxygen supplementation group (oxygen supplementation was administered routinely prior to and during the procedure at a rate of 2 L/min);
and (b) room air breathing group (room air was breathed during the procedure; oxygen supplementation was administered if SpO2 fell below 90% for more than 20-second intervals during the procedure).
On arrival at the endoscopy unit, the patient's medical history and records were obtained and carefully reviewed. An 
Of the 70 patients, 35 underwent sedated diagnostic colonoscopy with oxygen supplementation and 35 underwent the procedure while breathing room air. The demographic and clinical characteristics of patients in the two groups were similar (Table I) . In both groups, the underlying disease in the ASA class II patients were hypertension and diabetes mellitus. A supplemental dose of flunitrazepam for abdominal pain or discomfort was given to three patients in the oxygen supplementation group and two patients in the room air breathing group, but no supplemental meperidine was administered to any patient in either group. One patient in the oxygen supplementation group and two patients in the room air breathing group did not complete the colonoscopy due to abdominal discomfort and pain. There were no significant cardiopulmonary or endoscopic complications that required medical intervention in either group.
There were no significant differences in the baseline values of etCO 2 between the oxygen supplementation (37.1 ± 2.6 mmHg) and room air breathing (37.0 ± 2.6 mmHg) groups. After sedation, although alveolar hypoventilation caused an increase in etCO2 
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in each group, there was no significant difference in the peak etCO2 during the procedure between patients in the two groups (oxygen supplementation: 44.9 ± 4.1 mmHg vs. room air breathing: 44.1 ± 4.0 mmHg; p = 0.4). The mean increase in etCO2 at its peak from baseline was 7.7 ± 3.3 mmHg in the oxygen supplementation group and 7.0 ± 2.6 mmHg in the room air breathing group (Fig. 2) .
SpO2 before oxygen administration in the oxygen supplementation group was 97.9% ± 1.4%, which was nearly comparable to the baseline SpO2 value seen among patients in the room air breathing group (p = 0.21; data not shown).
The baseline SpO2 value was 99.2% ± 1.2% in the oxygen supplementation group and 97.3% ± 2.1% in the room air breathing group. After sedation, SpO2 decreased as alveolar hypoventilation developed in each group, and the SpO2 at peak etCO2 was significantly increased by more than 5% in the oxygen supplementation group when compared with the room air breathing group (98.6% ± 1.4% vs. 93.1% ± 2.9%; p < 0.001).
The mean reduction in SpO2 from baseline at peak etCO2 was significantly lower in the oxygen supplementation group than in the room air breathing group (0.5% ± 1.1% vs. 4.1% ± 3.1%; p < 0.001) (Fig. 3 ). There were no significant differences in the respiratory rate between the two groups at the time of baseline and peak etCO2.
DISCUSSION
Our study showed that the masking effect of oxygen supplementation resulted in an overestimation of SpO2 by greater than 5% above the values in patients breathing room air when peak alveolar hypoventilation occurred, although the decrease in SpO2 was only 0.5% below the baseline at that time. These findings demonstrate that SpO2 monitoring in oxygen supplementation provides little information about the adequacy of alveolar hypoventilation, as previously reported.
(1,2,5)
As SpO2 monitoring is the standard technique used during sedated endoscopy, and capnography is usually not available in the gastrointestinal endoscopy unit, physicians usually predict a patient's alveolar ventilation status during a sedated endoscopy procedure solely by SpO2 monitoring. When alveolar hyperventilation occurs in a patient breathing room air, SpO2 decreases rapidly; it is a useful indicator of alveolar ventilation as well as oxygenation. (5) However, when oxygen supplementation is given, the physician should note that alveolar hypoventilation may worsen after sedation even if a high SpO2 value is being recorded. Also, a decrease in SpO2 by just 1%, even if the value remains at 98%, should prompt the physician to consider the onset of severe alveolar hypoventilation or apnoea, which requires immediate intervention.
The indications for capnography during sedated endoscopy are widely contested. Sedation-related mortality in gastrointestinal endoscopy is generally very rare, with a prevalence ranging from 1/10,000 to 3/100,000. (8) (9) (10) Respiratory depression during procedural sedation is defined as SpO2 < 90%, etCO2 > 50 mmHg or apnoea (absence of etCO2 waveform). It is critical that respiratory depression be detected early so that intervention (such as reversal of sedation) can be implemented to prevent respiratory arrest, even if only one of these criteria is found to be applicable, regardless of the SpO2 value. (11) Capnography is considered to be superior to SpO2 for the detection of early respiratory depression during procedural sedation, (6, 7, 12) and it can detect alveolar hypoventilation even when oxygen supplementation is given; in this study, detection would have been impossible using SpO2 monitoring alone. Deep sedation strongly suppresses the patient's respiration and often causes upper airway obstruction and apnoea, which requires intervention and oxygen supplementation. Therefore, the authors propose that etCO2 monitoring is indispensable for endoscopy that requires deep sedation with routine oxygen supplementation. In contrast, mild-to-moderate sedation usually maintains the patency of the patient's upper airway and adequate spontaneous ventilation.
Thus, the routine use of capnography monitoring does not appear to reduce sedation-related comorbidity and may not be necessary for patients under mild-to-moderate sedation. (13) However, deep sedation frequently occurs during endoscopy despite the intent to induce moderate sedation, especially in patients undergoing endoscopic cholangiopancreatography and endoscopic ultrasonography. (14) A recent high-volume randomised controlled study showed that capnography-based ventilation monitoring for these types of elective endoscopy procedures significantly improved patient safety by reducing the frequency of hypoxaemia, severe hypoxaemia and apnoea. (15) Other potential predictors of respiratory compromise during sedated endoscopy are currently under investigation, and they include variables such as old age, history of cerebrovascular accidents, chronic obstructive pulmonary disease and cardiac disease, unfit physical status (ASA class III-V) and types of sedatives used. (3, 13, 16) ASA guidelines state that capnography should be considered for any patient receiving deep sedation, whose ventilatory function cannot be adequately observed during a procedure in which the sedation is performed by a nonanaesthesiologist. (17) This ASA statement is also cited in the guidelines of the American Society of Gastrointestinal Endoscopy. (18) This study is not without its limitations. While no significant respiratory events occurred in any of our patients, the clinical impact of monitoring etCO2 could not be ascertained in this study due to the small sample size and the relatively healthy state of our patients. Further studies are necessary in order to determine the usefulness of capnography in accurately monitoring patients' ventilation during sedated endoscopy under oxygen supplementation. Nonetheless, the present study highlights the pitfall of monitoring SpO2 alone in patients undergoing sedated endoscopy with oxygen supplementation, as it could lead to a possible delay in detecting alveolar hypoventilation.
